Straits Times Index
3,165.50 -16.47 (-0.52%) S&P 500
3,655.04 -38.19 (-1.03%) Dow
29,260.81 -329.60 (-1.11%) Nasdaq
10,802.92 -65.00 (-0.60%) BTC-USD
20,268.79 +1,398.61 (+7.41%) CMC Crypto 200
463.05 +29.95 (+6.92%)
Vertex Pharmaceuticals Incorporated (VRTX)
Pre-market:
- Business Wire
Vertex and CRISPR Therapeutics Announce Global exa-cel Regulatory Submissions for Sickle Cell Disease and Beta Thalassemia in 2022
BOSTON & ZUG, Switzerland, September 27, 2022--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and CRISPR Therapeutics (Nasdaq: CRSP) today announced that Vertex has concluded discussions with the U.S. Food and Drug Administration (FDA), and the FDA granted exagamglogene autotemcel (exa-cel) a rolling review for the potential treatment of sickle cell disease (SCD) and transfusion-dependent beta thalassemia (TDT). Vertex will submit its biologics licensing application (BLA) for exa-cel for rol
- Motley Fool
S&P 500 Bear Market: Where to Invest $10,000 Right Now
After an all-too-short bounce, the S&P 500 is again in a bear market. The Nasdaq Composite Index has been firmly in bear market territory for weeks. Arguably the smartest place to park $10,000 right now is in the U.S. Treasury's Series I savings bonds.
- Motley Fool
Is Now the Right Time to Be Buying Growth Stocks?
There are plenty of fierce headwinds in play, but that doesn't mean you should sit on the sidelines.
